Table 1 Comparison of clinicopathological factors between the asymptomatic and symptomatic groups (all cases).
 | Asymptomatic MBC (n = 114) | Symptomatic MBC (n = 90) | p-value |
---|---|---|---|
Agea, years | 59.5 (36–88) | 59 (26–91) | 0.93 |
Recurrence-free survival, months | 40.5 (4–237) | 41 (4–309) | 0.99 |
Visceral metastasisa | 70 (61.4%) | 48 (53.3%) | 0.32 |
Multiple metastatic sitesa | 40 (35.1%) | 48 (53.3%) | 0.01 |
Metastasis siteb | |||
Lung | 46 | 29 | 0.25 |
Bone | 40 | 36 | 0.56 |
Lymph node | 33 | 36 | 0.10 |
Liver | 32 | 15 | 0.07 |
Chest wall | 3 | 17 |  < 0.001 |
Brain | 4 | 7 | 0.22 |
Stage 0/1/2/3 | 1/22/44/43/4 | 0/12/48/26/4 | 0.49 |
Subtype Luminal/HER2/Triple negative | 75/27/12 | 45/23/22 | 0.02 |